Skip to main content
PTC’s STRIVE Awards Funds Initiatives Supporting the Duchenne Patient Community
Main Menu
Search:
Submit
About PTC
Back
History
Leadership
Our Responsibility
Global Compliance Program
Gene Therapy Center of Excellence
Locations
Our Science
Back
Nonsense Suppression
Splicing
Bio-e
Our Pipeline
Therapeutic Areas
Back
Metabolism
Back
Familial chylomicronemia syndrome (FCS)
Familial partial lipodystrophy (FPL)
Phenylketonuria (PKU)
Neurology
Back
Amyotrophic lateral sclerosis (ALS)
Aromatic l-amino acid decarboxylase (AADC) deficiency
Duchenne muscular dystrophy (DMD)
Friedreich ataxia (FA)
Hereditary Transthyretin Amyloidosis (hATTR)
Huntington's Disease (HD)
Spinal muscular atrophy (SMA)
Oncology
Back
Diffuse intrinsic pontine glioma (DIPG)
Leiomyosarcoma (LMS)
Careers
United States
Back
Start of Column
Americas
United States
Start of Column
Europe
Austria
Germany
Ireland
Italy
Spain
Sweden (EN)
Sweden
Switzerland
United Kingdom
Investors
Healthcare Providers
Patients & Caregivers
Search:
Submit
United States
Start of Column
Americas
United States
Start of Column
Europe
Austria
Germany
Ireland
Italy
Spain
Sweden (EN)
Sweden
Switzerland
United Kingdom
Investors
Healthcare Providers
Patients & Caregivers